Effective synthetic peptide vaccine for foot-and-mouth disease in swine

Vaccine

Volumn 20, Issue 19-20, 2002, Pages 2603-2610

  Wang, Chang Yi ^a,b   Chang, Tseng Yuan ^a,b   Walfield, Alan M ^a   Ye, John ^a   Shen, Ming ^a   Chen, Shih Ping ^c   Li, Ming Chang ^c   Lin, Yeou Liang ^d   Jong, Ming Hwa ^d   Yang, Ping Cheng ^c   Chyr, Nancy ^b   Kramer, Ed ^e   Brown, Fred ^e  

^a United Biomedical Inc   (United States)

^b United Biomedical Inc Asia   (Taiwan)

^c Pig Research Institute Taiwan   (Taiwan)

^d FISHERIES RESEARCH INSTITUTE   (Taiwan)

^e PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

FMD; Peptide; Vaccine

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; PROTEIN VP1; CAPSID PROTEIN; PEPTIDE; VIRUS VACCINE; VP1 PROTEIN, FOOT AND MOUTH DISEASE VIRUS; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CROSS REACTION; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GUINEA PIG; IMMUNOLOGY; MOLECULAR GENETICS; STANDARD;

AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CROSS REACTIONS; FEMALE; FOOT-AND-MOUTH DISEASE; GUINEA PIGS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; SWINE; VIRAL VACCINES;

EID: 0037036196     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00148-2     Document Type: Article

References (32)

1. Managing foot-and-mouth: The science of controlling disease outbreaks
2. Location and characterisation of the antigenic portion of the FMDV immunising protein
3. Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence
4. Antibodies against a preselected peptide recognise and neutralise foot and mouth disease virus
5. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution
6. Protection of cattle against foot-and-mouth disease by a synthetic peptide
7. New approaches to vaccination against foot-and-mouth disease
8. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants
9. Association of Bovine DRB3 Alleles with immune response to FMDV peptides and protection against viral challenge
10. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T cell determinants
11. Synthetic peptide vaccines: Success at last
12. High-affinity antibody induced by immunisation with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease
13. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C
14. Neutralising antibodies to all seven serotypes of foot-and mouth disease virus elicited by synthetic peptides
15. Delineation of a neutralising subregion within the immunodominant epitope (G-H loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif
16. Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA
17. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle
18. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: Identification of T helper epitopes in VP1
19. A 10-amino acid linear sequence of VP1 of foot-and-mouth disease virus containing B and T cell epitopes induces protection in mice
20. Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain
21. Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock
22. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA
23. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB, 3ABC in ELISA using antigens expressed in Baculovirus
24. Cyclic peptides as conformationally restricted models of viral antigens: Application to foot-and-mouth disease virus
25. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host
26. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acids)
27. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and mouth disease virus to tissue culture cells
28. RGD sequence of foot-and mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway
29. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus
30. Protective immune response against foot-and-mouth disease